 Economic Times |
India revokes patent for Merck asthma drug
Economic Times NEW DELHI: India has revoked a patent for an asthma drug held by US-based Merck following a challenge from local pharmaceutical giant Cipla, marking a new blow to global drug firms in the Indian market. The development is the latest in a string of … India revokes patent on Merck asthma drug Merck loses patent for asthma drug India Revokes Patent on Merck Asthma Drug -Reuters |
View full post on asthma – Google News